Effect of Ayurvedic Medicated Retention Enema in Parkinsons Disease when compared to Conventional Treatment
Phase 3
- Conditions
- Health Condition 1: G20- Parkinsons disease
- Registration Number
- CTRI/2023/07/055050
- Lead Sponsor
- Shilpa thengil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Scores Of Tremor,Rigidity,Bradykinesia,Postural Instability And Non Motor Symptoms Not More Than 3
Exclusion Criteria
1.Using Drugs For Other Systemic Illness
2.Other Neurological Illness Or Treatment
3.Haemarrhoids
4.Pregnancy
5.Wheel Chair Bound/Bedridden
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in scores of UPDR scaleTimepoint: 0th Day <br/ ><br>14th Day <br/ ><br>42ND Day
- Secondary Outcome Measures
Name Time Method Cell line study of Ashwagandha ghrithaTimepoint: 1 month <br/ ><br>;Standardize raw drug AshwagandhaTimepoint: 1 Month